Retropubik radikal prostatektomi sonrasi erektil disfonksiyon ve tedavisi

Translated title of the contribution: Erectile dysfunction and treatment after retropubic radical prostatectomy

Tolga Akman, Öner Şanli, Ateş Kadioǧlu

Research output: Contribution to journalReview articlepeer-review

1 Scopus citations


Introduction: The incidence of erectile dysfunction in men following radical prostatectomy has been estimated to range between 16% and 82%. The most important predictors of erectile function are preoperative erectile function and nerve sparing nature of the procedure. The former is determined by age and vascular risk-factors whereas the latter is decided by the stage of the tumor and the skill of the surgeon. Apoptosis of corporeal smooth muscle cells plays a significant role in the development of cavernosal dysfunction following radical prostatectomy. Symptomatic therapy may be applied according to the current general standards of treatment in men with erectile dysfunction (ED). In addition, pharmacological prophylaxis and treatment of postoperative ED with different treatment alternatives is effective and safe, and PDE5 inhibitors have similar outcome after radical prostatectomy. The concepts of cavernous nerve reconstruction and neuroprotection have been associated to promising results.

Translated title of the contributionErectile dysfunction and treatment after retropubic radical prostatectomy
Original languageTurkish
Pages (from-to)186-196
Number of pages11
JournalTurk Uroloji Dergisi
Issue number2
StatePublished - Aug 8 2005


  • Cavernous nerve
  • Erectile dysfunction
  • PDE5 inhibitors
  • Prostate cancer
  • Radical prostatectomy

ASJC Scopus subject areas

  • Urology


Dive into the research topics of 'Erectile dysfunction and treatment after retropubic radical prostatectomy'. Together they form a unique fingerprint.

Cite this